With rigorous economic research and practical policy solutions, we focus on the issues and institutions that are critical to global development. Explore our core themes and topics to learn more about our work.
In timely and incisive analysis, our experts parse the latest development news and devise practical solutions to new and emerging challenges. Our events convene the top thinkers and doers in global development.
CGD research brings an economic perspective to the global fight against major killers, including HIV, tuberculosis, and malaria. We help governments and international agencies, including the Global Fund, find ways to catalyze development of new, effective drugs, as well as how to make fair decisions about who should get treatment for what disease at what cost—and the implications of those decisions.
Last week, Gavi, the Vaccine Alliance, completed a $7.5 billion replenishment to fund its work on immunization in the world’s poorest countries between now and 2020. Gavi’s next step is to ensure that the money is used as effectively as possible to save lives and improve health.
Six months have passed since the WHO declared the current outbreak of Ebola Virus Disease in West Africa a Public Health Emergency of International Concern. This declaration set in motion an international response to curb the spread of the disease. While far from over, there are signs that the epidemic is starting to come under control and that the outbreak is moving into a new phase.
Rebuilding and strengthening Liberia’s health systems, investing in households with young children, and revitalizing the private sector must be made priorities for Liberia, according to experts gathered at CGD for an event on what the international community can do to help the country’s people and economy recover from the toll of Ebola.
This post is informed by a December 18, 2014, CGD roundtable discussion on Ebola.
The biggest outbreak of Ebola in history has taken a tragic toll in West Africa: almost 21,000 cases and more than 8,000 deaths in Guinea, Liberia, and Sierra Leone. The crisis is far from over and the first priority is to reach zero cases.
In a nearly unprecedented gesture for a sitting head of state, Liberian President Ellen Johnson Sirleaf joined the Senate Foreign Relations African Affairs subcommittee hearing on “The Ebola Epidemic: The Keys to Success for the International Response” to provide a statement, as well as to answer questions.